New Drug Applications FDA Accepts Genentech’s Biologics License Application for Fixed-Dose Subcutaneous Combination of Perjeta And Herceptin For HER2-Positive Breast Cancer 5 years ago
Healthcare News COVID-19 Pandemic: Study Predicts Scary Future With More Restrictions, Deaths 5 years ago
New Drugs FDA Approves Epclusa (sofosbuvir/velpatasvir) for Children Ages 6 and Older or Weighing at Least 17 kg with Chronic Hepatitis C Infection 5 years ago